Table 2.

Incidence of adverse reactions in both groups

Classification	Group A (n=53)	Group B (n=57)	X2	P
Epilepsy	2 (3.77)	1 (1.75)	-	-
Gastrointestinal bleeding	1 (1.89)	1 (1.75)	-	-
Pulmonary infection	2 (3.77)	0 (0.00)	-	-
Arrhythmia	2 (3.77)	1 (1.75)	-	-
Total incidence of adverse reactions	13.21%	5.26%	1.341	0.247